Right-left bicuspid aortic valve (R-L BAV) is the most frequent phenotype of the most common congenital heart disease. Its etiology is based on two associated morphogenetic defects during cardiac outflow tract (OFT) septation: abnormal migration of cardiac neural crest (CNC) cells, and excessive fusion of the conal ridges (CRs). The aim of this study is to elucidate the mechanism involved in the fusion of the CRs responsible for normal and abnormal OFT septation and BAV formation. Two mechanisms have been proposed: endocardial apoptosis and endocardial-mesenchymal transition (EMT). The involvement of these mechanisms in the fusion event was tested in embryos of the hamster model with BAV. Apoptotic cells were absent in the fusion area of the CRs. However, we detected endocardial cells (CD34(+);VE-Cadherin(+)) showing positive signals for migration markers (α-actin(+)) in the fusion area of the CRs of embryos developing both normal aortic valve and BAV. These cells showed an intermediate morphological phenotype between endocardial and mesenchymal cells. The findings clearly indicate that EMT, and not apoptosis, is the cellular mechanism underlying the normal and excessive fusion of CRs that give rise to tricuspid aortic valve and BAV, respectively. Furthermore, our results show that the fusion of CRs in embryos developing BAV continues after the OFT septation, suggesting over-induction of EMT by abnormally distributed CNC cells.
Endocardial-to-mesenchymal transition underlies cardiac outflow tract septation and bicuspid aortic valve formation in the Syrian hamster model.
在叙利亚仓鼠模型中,心内膜间质转化是心脏流出道隔膜形成和二叶式主动脉瓣形成的基础
阅读:4
作者:Soto-Navarrete MarÃa Teresa, Pozo-Vilumbrales Bárbara, López-Unzu Miguel Ã, MartÃn-Chaves Laura, Durán Ana C, Fernández Borja
| 期刊: | Scientific Reports | 影响因子: | 3.900 |
| 时间: | 2025 | 起止号: | 2025 Mar 12; 15(1):8583 |
| doi: | 10.1038/s41598-025-91454-6 | 研究方向: | 其它 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
